TrialDiabetes, obesity & metabolism2009

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.

M J Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.